Stocks and Investing Stocks and Investing
Tue, September 27, 2022
Mon, September 26, 2022

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Decreased Target to $6 on, Sep 26th, 2022


Published on 2024-10-27 23:06:29 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Decreased Target from $7 to $6 on, Sep 26th, 2022.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $8 on, Friday, September 23rd, 2022
Contributing Sources